Corporate News

Director Dealing

11 October 2019

Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product, announces that it was notified on 10 October 2019 that Dr Jonathan Allis, a Non-Executive Director of the Company, purchased 1,540,000 Ordinary Shares of £0.00037 ("Ordinary Shares") at a price of 13.06 pence per share on 8 October 2019.

Following this transaction, Dr Allis now holds a beneficial interest in 1,540,000 Ordinary Shares, representing approximately 1.35 per cent. of the Company's issued share capital.

Enquiries:

Polarean Imaging plc	www.polarean.com/www.polarean-ir.com
Richard Hullihen, Chief Executive Officer	Via Walbrook PR
Richard Morgan, Chairman

SP Angel Corporate Finance LLP	Tel: +44 (0)20 3470 0470
David Hignell / Lindsay Mair / Jamie Spotswood (Corporate Finance)
Vadim Alexandre / Rob Rees (Corporate Broking)

Walbrook PR	Tel: +44 (0)20 7933 8780 or[email protected]
Anna Dunphy / Paul McManus	Mob: +44 (0)7879 741 001 / +44 (0)7980 541 893

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Dr Jonathan Allis

2.

Reason for the notification

a)

Position/status:

Non-Executive Director

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Polarean Imaging Plc

b)

LEI:

213800DGR2BHXJ36OL37

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Identification code:

Ordinary shares of £0.00037

GB00BF3DT583

b)

Nature of the transaction:

Purchase of shares

c)

Price(s) and volume(s):